David M. Spencer
Plus aucun poste en cours
Historique de carrière de David M. Spencer
Anciens postes connus de David M. Spencer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 14/07/2004 | 01/03/2019 |
| Fondateur | 14/07/2004 | 01/03/2019 | |
| KIROMIC BIOPHARMA, INC. | Directeur/Membre du Conseil | 01/10/2019 | - |
| Directeur Technique/Scientifique/R&D | 01/10/2019 | - | |
| Baylor College of Medicine | Corporate Officer/Principal | - | - |
Formation de David M. Spencer
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KIROMIC BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Bourse
- Insiders
- David M. Spencer
- Expérience
